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Abstract
Background: A major site of initiation of inflammatory responses upon physical perturbation(s) and infection by 
invading organisms is the skin. Control of responses in this organ is, in part, modulated by the neuronal nicotinic 
acetylcholine receptor (nAChR) alpha7.
Methods: To further investigate the role of alpha7 in skin inflammatory responses, a local inflammatory response was 
induced by topical application of croton oil to the ear skin of wild-type (alpha7WT) and alpha7 knock-out (alpha7KO) 
mice. Cells infiltrating the inflamed tissue were characterized by flow cytometry and RNA analysis.
Results: Six hours following croton oil application, analysis of infiltrating cells showed that the alpha7KO mice 
exhibited a significantly enhanced number of cells, and specifically, of Ly6G positive neutrophils. Macrophage and 
lymphocyte infiltration was equivalent in the alpha7KO and alpha7WT mice. RNA analysis showed that IL-1β and IL-6 
were increased significantly in the infiltrating cells of the alpha7KO mouse, although TNF failed to reach significance. In 
contrast, resident cells of the skin exhibited no differences in these cytokines between genotypes. Both resident and 
infiltrating cell populations from alpha7KO mice did show elevated message levels for the adhesion protein ICAM1. 
Measurement of chemokines revealed enhanced expression of the skin-related CCL27 by resident cells in alpha7KO 
mice. Further, we demonstrate that the population of Ly6G+ neutrophils at the croton oil-inflamed skin site expresses 
low levels of CCR10, a receptor for CCL27 normally associated with lymphocytes.
Conclusion: nAChRalpha7 in the skin can impact on early local inflammatory responses mediated through a novel 
population of neutrophils that are Ly6G+CCR10lo.
Background
Neuronal nicotinic acetylcholine receptors (nAChR) are
well characterized for their role(s) in modulating neu-
rotransmission including the addictive response to nico-
tine [1,2]. However, these ligand-activated ionotropic
receptors, particularly the distinct subtype termed alpha7
(α7), also participate in non-neuronal peripheral systems
to impact upon pro-inflammatory responses [3-6]. Not
unlike α7 in the nervous system, the effects of α7 activity
peripherally can vary greatly depending upon where it is
expressed and in which cell type. In neurons, the α7
receptor antagonizes TNFα-induced neuroprotection in
primary cultures; and in peripheral organs receiving vagal
innervation, the α7 receptor impacts upon inflammatory
responses [4,7]. A robust contribution by α7 towards
modulating inflammatory cytokine production in the
skin is also present and occurs independently of vagal-
parasympathetic innervation (e.g. see discussion in [3,8]).
Keratinocytes appear to be the primary source of acetyl-
choline (ACh) in the skin [4] but further investigation
regarding other cell sources is needed.
The skin is a first line of defense against many patho-
genic agents and is exposed to many external agents that
are pro-inflammatory (e.g., UVB or sunburn and topical
irritants) as well as to agents that modify α7 function
such as nicotine. Almost 30 years ago it was recognized
that nicotine could alter wound healing in rabbit ears [9].
Since then, it has been further demonstrated that kerati-
nocytes express nicotinic receptors and modulation in
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tinic receptors α3, α4, α5 and α7 [10-13]. Keratinocyte
expression of α7 has been demonstrated using in situ
hybridization, double-labeling immunofluorescence, and
patch-clamp studies [14,15], and respond to nicotine. In
tissue culture systems, Grando et al. [16] have demon-
strated that nicotine increases cell-cell adherence of cul-
tured keratinocytes and stimulates their lateral migration.
The data presented here will demonstrate that α7 can also
modulate the inflammatory response in skin that has
been treated with croton oil.
Chemokines are another component of the inflamma-
tory process that are crucial for the development of the
appropriate response in specific tissues. This includes the
skin, which has a distinct expression pattern of chemok-
ines and their receptors (e.g., [17-19]). Chemokines are
secreted basic proteins that bind to glycosaminoglycans
on cell surfaces or the extracellular matrix [19,20]. There-
fore, chemokines can be released into the circulation but
also remain concentrated at specific sites of injury. Leu-
kocytes in the bloodstream establish a loose tethering
interaction with the endothelium which is mediated by
selectin and integrin molecules such as E-selectin and α4
and β2 integrins [20,21]. This initial interaction slows the
responding cell (e.g., neutrophils and lymphocytes) down
and allows it to roll along the endothelium where it inter-
acts with other cell surface receptors including
chemokine receptors. The adhesion of leukocytes to the
endothelium then induces intracellular signaling cascades
and leads to cellular reorganization and migration of the
leukocyte into the target tissue [19,20]. Once inside the
target tissue, the leukocyte will release inflammatory
mediators where they in turn carry out specific functions.
This study continues the investigation of how
nAChRα7 influences the inflammatory response through
measurements of pro-inflammatory cell recruitment
induced by local inflammation in the skin. To do this,
croton oil was topically applied to the ear and infiltrating
cells were isolated and characterized using flow cytome-
try. nAChRα7KO mice exhibited significant increases of
Ly6G positive neutrophils relative to controls (α7WT) at
the site of inflammation. RNA analysis of both infiltrating
and resident cells revealed increased IL-1β and IL-6 (but
not TNFα) in α7KO infiltrates as well as certain adhesion
proteins such as ICAM1 (especially by resident cells).
There was also an increase in the expression of the
CCR10 chemokine receptor by infiltrating cells, as wells
as an increase in the ligand for this receptor, CCL27, by
resident cells. Because these chemokines are important
mediators of pro-inflammatory cell recruitment to the
skin, our results advance the idea that α7 influences




These studies were IACUC approved. All mice were
housed in a pathogen free environment with water and
standard mouse chow provided ad libitum. Each experi-
ment used groups of 3-5 mice that were age (3 to 6
months old), gender and strain matched. Wild-type (WT)
and α7KO mice in the C57BL/6 background were initially
purchased from Jackson Laboratories (Bar Harbor, ME)
and subsequently maintained as a breeding colony in our
animal facility. The α7KO and α7WT mice are routinely
generated by breeding mice that are α7WT/KO heterozy-
gotes to provide homozygote litter-mate mice of both
α7KO and α7WT genotypes. The α5 (WT and KO) and
β4 (WT and KO) mice are also maintained in breeding
colonies in the University of Utah Comparative Medicine
Department.
Isolation of ear infiltrates
The ears of α7WT or α7KO mice were treated with 10 μl
of croton oil (Sigma, St Louis MO), that was diluted to a
final concentration of 3.5% in 4:1 acetone: olive oil, on
each side of their ears for a total of 20 μl per mouse ear.
Inflammation was allowed to develop for 6 hrs before
mice were sacrificed and the ears were collected.
Inflamed ears were briefly dipped in 70% ethanol and PBS
and separated with sterile forceps into dorsal and ventral
layers. Each ear half was floated dermal side down over-
night in RPMI media (Cellgro/Mediatech, Hernden, VA)
supplemented with penicillin/streptomycin (Cellgro/
Mediatech, Hernden, VA) and Hepes buffer (Cellgro/
Mediatech, Hernden VA). The following day, infiltrate
depleted ear halves were removed, and infiltrating cells
were collected from the media. Cells were then washed
with cold PBS and centrifuged at 1600 rpm, 4°C for 10
minutes. The ear tissue depleted of infiltrating cells was
frozen (-80°C) and saved for RNA analysis. It should be
noted that no cells were present in the media from ears of
mice if an inflammatory stimulus (croton oil) was not
first applied. Further, at times prior to 6 hours of croton
oil exposure, minimal cells were isolated from ears mak-
ing analysis of these cells difficult.
Isolation of bone marrow and spleen cells
Marrow from femurs and tibias was extracted by cutting
off the ends of the bones and flushing the shaft with ice-
cold PBS using a 25-gauge needle and 3cc syringe. The
resulting mixture was passed through the needle and
syringe once to obtain a single-cell suspension. Cells were
centrifuged at 4°C, 1600 rpm for 5 minutes, and then
resuspended in erythrocyte lysis buffer (0.14 M Ammo-
nium Chloride, 17 mM Tris in H20) for 5 minutes at 25°C.
Cells were washed with 10 ml ice-cold PBS, centrifuged,
and collected for further analysis. Similarly, spleens were
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pensions were then treated with ammonium chloride to
lyse red blood cells, washed and collected for further
analysis.
Cell cytometry analysis
To analyze cells by flow cytometry, cells were counted
with a hemocytometer and 0.5 to 1 × 106 cells were resus-
pended in 1 ml PBS, and placed into tubes on ice. For all
samples, Fc receptors (Fc block, BD Bioscience Pharmin-
gen, San Jose, CA) were blocked using 1 μg per 106 cells
for 15 minutes on ice. The effectiveness of this block was
tested by subsequent staining for FcR using labeled 2.4G2
antibody which routinely showed complete block. Anti-
bodies were added to the cell samples at a concentration
of 1 μg per 106 cells and incubated for 30 minutes on ice
in the dark (FITC-conjugated anti-Ly6G, anti-CD45R/
B220, anti-CD4, anti-CD8α from BD Bioscience
Pharmingen, San Jose, CA; PE-conjugated anti-Ly6C (BD
Bioscience Pharmingen, San Jose, CA), anti-CCR10
(R&D Systems, Minneapolis, MN), anti-F4/80 from eBio-
science, San Diego, CA). Isotype controls to assess non-
specific binding were FITC- or PE-conjuated rat IgG2a
and PE-conjugated rat IgG2b (BD Biosciences Pharmin-
gen, San Jose, CA). Following incubation with antibodies,
cells were washed with PBS and filtered through 85
micron nylon mesh (Small Parts Company, Miami Lakes,
FL) to remove aggregated cells. Samples were analyzed
using either a Becton Dickinson FACScan instrument or
an Accuri Cell Cytometry System (Ann Arbor, Michigan).
Data were analyzed with FlowJo Software (Ashland, OR).
Histogram data are expressed as percentage of maximum
according to standard flow cytometric analysis in which
peak heights within each graph are normalized to a per-
centage of the peak representing the highest event num-
ber on the X axis. The highest event number is based on
'bins' which are numerical ranges for the parameter on
the X axis (as described in the Flowjo.com for cell cytom-
etry histogram generation). Data displayed as percent of
Max allows for visual comparison of samples with differ-
ent event numbers collected.
RNA isolation for arrays and real-time PCR
To extract RNA, cells were placed in Trizol (Invitrogen,
Carlsbad CA), and processed for RNA according to the
manufacturer's instructions. Ear skin (devoid of infiltrat-
ing cells) was also placed in Trizol and homogenized with
a tissue tearor (Biospec Products, Bartlesville, OK). Man-
ufacturers' directions were then followed for RNA isola-
tion. RNA was precipitated in isopropanol and washed in
75% ethanol at room temperature. The concentration and
purity of the RNA was determined with a ND-1000 Spec-
trophotometer (NanoDrop Technologies, Wilmington
DE). A 1 μg sample of each RNA was DNase treated and
converted via reverse transcription PCR to cDNA (Pro-
mega, Madison WI) and used to amplify cDNA (high
capacity cDNA Archive Kit, Applied BioSystems, Foster
City CA). 20 ng of cDNA was loaded into each well and
the following TaqMan Gene Expression Assays were
used: ICAM1 (Mm00526023_m1), Itga3
(Mm0042890_m1), Itgb2 (Mm00434513_m1), E-Selectin
(Mm00441278_m1), IL1-β (Mm00434228_m1), IL-6
(Mm00446190_m1), TNFα (Mm00443258_m1), CXCL1
(Mm00433859_m1), CXCL5 (Mm00436451_g1), CXCL9
(Mm0043494_m1), CCL1 (Mm00441236_m1), CCL2
(Mm00441242_m1), CCL3 (Mm00441258_m1), CCL4
(Mm00443111_m1), CCL5 (Mm01302427_m1), CCL11
(Mm00441238_m1), CCL27 (Mm00441257), CCL28
(Mm00445039_m1), GAPDH (4352339E), β-actin
(4352341E) (Applied Biosystems, Foster City CA).
GAPDH and β-actin were used as internal control genes,
and all samples were run in duplicate. Fold-changes in
RNA expression were calculated relative to RNA from
matched control animals, and was determined using the
comparative Ct method (Applied Biosystems). RNA from
both skin tissue and infiltrating cells was also analyzed in
duplicate using Mouse Inflammatory Cytokines and
Receptors RT2 Profiler PCR Arrays (SABiosciences,
Mouse Inflammatory Cytokines and Receptors, PAMM-
011E) according to manufacturers' directions. Briefly,
RNA was converted to cDNA using the RT2 First Strand
Kit, and amplified using RT2 SYBR green/ROX qPCR
master mix (SABiosciences, Frederick, MD). WT tran-
script levels for each experiment were normalized to a
value of 1 to allow generation of fold change values in the
alpha7KO in each experiment, and to compare fold
change with the KO between experiments. Error bars
reflect the standard error of the mean as calculated from
3 independent experiments with 5-6 mice per experimen-
tal group.
Results
Infiltration of pro-inflammatory cells is modified by α7 
expression
The mouse ear pinna provides a unique site to study cel-
lular infiltration following skin inflammation. This is due
to the distinct dorsal and ventral sides, each with an epi-
dermal and dermal layer, that are separated by auricular
cartilage. Upon application of an inflammatory agent,
cells collect between the dorsal and ventral ear skin and
infiltrate the tissue. The infiltrating cells are recovered
from the media after mechanical separation of the ear
into the respective halves, and overnight incubation of
the ear halves in media allows cells to be released into the
media. This procedure results in the isolation of recruited
cells without using more disruptive interventions that can
inconsistently impact upon cells more sensitive to harsh
isolation conditions. To examine an inflammatory
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method of topical application of croton oil, an organic
phorbol compound derived from the seeds of the Croton
tiglium tree. A particular advantage of this method is the
relatively mild inflammatory response which could facili-
tate detection of α7 modulatory components. Mouse ears
were treated with topically applied 3.5% croton oil to
induce local inflammation. At six hours post croton oil
application, the mice (groups of 5 α7WT or α7KO) were
sacrificed and the ears removed. The dorsal and ventral
sides of the ear were separated and incubated overnight
in media (see Methods). The results presented in Figure
1a show that the total number of cells isolated from α7KO
mice is significantly (p < 0.01) enhanced relative to wild-
type mice. Cell numbers reflect the total number of cells
obtained from 5 mice in each group. The standard error
of the mean is derived by averaging the number of cells
obtained from each of these groups (WT or KO) from at
least 5 separated experiments. In the absence of an
inflammatory stimulus such as croton oil, there are too
few cells to isolate and characterize. Further, we have
found that the overnight incubation of the ear halves is
required to obtain the infiltrating cells suggesting that the
cells are not just in the edematous fluid of the ear.
To determine if infiltrating cells from α7WT and α7KO
mice differ in cytokine production, quantitative real-time
PCR (qPCR) of key pro-inflammatory cytokine RNAs
was done using Taqman gene expression assays. The
cytokines examined were previously shown to differ
between WT and KO mice upon ultraviolet radiation
exposure to defined skin sites [8]. There was greater IL-
1β and IL-6 (p < 0.05) in the α7KO cells relative to infil-
trating cells from the α7WT mouse (Figure 1b). However,
other cytokine RNA expression such as for TNFα, while
elevated in the α7KO infiltrates, was not statistically dif-
ferent between genotypes. In the ear tissue remaining
after depletion of infiltrating cells the expression of IL-1β,
IL-6 or TNFα RNA did not differ between α7WT and
α7KO mice (Figure 1c). There was, however, a substantial
decrease in TNFα in the ear skin of both the α7WT and
α7KO mice treated with croton oil. Thus in skin receiving
croton oil there is an overall increase in the number of
cells recruited to the site of inflammation in the α7KO
mouse relative to α7WT. Infiltrating cells have elevated
IL-1β and IL-6 message in the α7KO compared to WT
animals while the resident skin cells of the WT and KO
mice express equivalent amounts of these cytokines.
Neutrophil infiltration to the site of skin inflammation is 
enhanced in the α7KO mouse
The identity of the infiltrating cells at the site of inflam-
mation following croton oil application was determined
using flow cytometry and markers specific for neutro-
phils (Ly6G; PMNs: polymorphonuclear cells), mature
macrophages (F4/80; [22]), B-cells (B220) and T-cells
(helper T-cells, CD4 or cytotoxic T-cells, CD8). As shown
in Figure 2, there was a dramatic difference in infiltration
by neutrophils to the site of inflammation in the α7KO
when compared to the α7WT (Figure 2a). Staining with
an isotype (FITC-IgG2a) control for the anti-Ly6G anti-
body resulted in a histogram that is identical to the
unstained controls (data not shown). Results are
expressed as percentage of the maximum response and
percent of Ly6G positive cells is reflected by the percent-
age above the peak response (α7KO, 54%; α7WT 33.6
percent neutrophils). The increase in Ly6G+ cells in the
α7KO is also observed in α7KO mice that are in the C3H
background (not shown) indicating that while B6 and
C3H mouse strains may differ substantially in response to
nicotine (e.g., see [2]), the results measured here are inde-
pendent of mouse strain backgrounds. The increase in
PMNs recruited in the α7KO mouse was consistently
measured using either the anti-Ly6G antibody or anti-
Ly6C antibody (which detects PMNs as well as other
granulocytes, as in Figure 2c). The small difference in
intensity of staining with F4/80, B220, or CD4 antibodies
was not consistently observed, nor was the small decrease
in intensity of staining with the anti-CD8 antibody (Fig-
ure 2b). The possibility that increased PMN recruitment
in the α7KO mouse is representative of a difference in the
composition of bone marrow in the α7KO mouse was
examined. Bone marrow was extracted from mice of each
genotype and antibodies to cell type specific markers
were used to determine the percentage of neutrophils,
macrophages and B cells. The results shown in Figure 2c
show no difference between α7WT and α7KO mice in
number of Ly6G+ neutrophils or Ly6C+ granulocytes or
other cell types (not shown) in the bone marrow. Further,
the spleen, while not a major site of neutrophil residence
or source for recruitment, also showed no difference in
neutrophils the between WT and KO mice.
Because nicotinic receptors such as α5 and β4 are also
expressed in peripheral systems (especially in ganglia;
[1]), the specificity of the influence of α7 on enhanced
neutrophil infiltration was examined. As described
above, croton oil was applied to ears of mice having either
the nAChRα5 or nAChRβ4 subunit ablated (α5KO or
β4KO, respectively). The α5KO was selected because the
absence of expression by this subunit has been implicated
in altering the course of other inflammatory-related dis-
eases [23] and in some cases it has been suggested to
interact with α7 to form heteromeric receptors with func-
tional differences uniquely distinct from α7 homomeric
receptors [1]. The β4 subunit is the principal beta subunit
of nAChRs in peripheral nerve tissue such as autonomic
ganglia [1]. Further, while mice tolerate ablation of β4,
presumably due to compensation by the β2 subunit, the
function of the receptor and response to external agents
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subunit forms a functional receptor when expressed
alone [1]. As shown for neutrophil skin infiltrates in Fig-
ure 2d, no difference was observed for either of the α5KO
or the β4KO mice relative to appropriately matched WT
litter-mate controls. Further, neither the α5KO nor the
β4KO exhibit any other difference in cellular infiltration,
such as macrophages or lymphocytes (not shown). Thus,
the effects related to α7 expression are not the result of a
more broad disruption of nAChRs expressed in ganglia or
other peripheral sites or of non-specific genetic manipu-
lations used to generate these mice.
To determine whether the increase in neutrophils in
the inflamed ear of the α7KO mouse persists at later time
points, ears were harvested 24 hours after croton oil
application. Results obtained indicate that no difference
Figure 1 The local inflammatory response to croton oil is enhanced in the α7KO mouse. Ears of WT and α7KO mice (5 animals/experiment) were 
treated with croton oil. Six hours post-treatment ears were removed, dorsal and ventral halves separated before floating them dermis side down on 
media overnight. A) Total number of cells isolated per treatment group was then measured (99% viability, not shown). The light grey bars represent 
WT mice and dark grey bars the α7KO. Error bars reflect ± of the standard error of the mean of all experiments (3-5 experiments per group); * p < 0.05 
and **, p < 0.01 (two-tailed Student's T-test). B) Expression of key pro-inflammatory cytokine transcripts from infiltrating cells using qPCR (Methods). 
The average fold increase normalized to a value of 1 for IL-1β, IL-6 and TNFα from α7WT mice (light grey) and α7KO (grey bars) are compared. Error 
bars reflect the standard error of the mean from 3 independent experiments with 5-6 mice per experimental group. C) Analysis of transcripts from ear 
skin after removal of infiltrating cells from untreated mice, or mice treated with croton oil. The expression of these cytokines does not differ between 
α7WT and α7KO. Light gray bars represent ear skin from WT mice and dark gray for α7KO mice. Non-shaded bars represent ear skin from untreated 
WT mice. Ear skin RNA amounts recovered did not differ between genotypes (not shown).
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Figure 2 Croton oil treatment of α7KO mice selectively enhances neutrophil infiltration into ears 6 hours post-croton oil application. A) 
Flow cytometry of infiltrating cells from the α7WT (upper) or α7KO (lower) mice reveals a substantial difference in the infiltration by Ly6G+ neutrophils 
6 hours following croton oil treatment. Similar results were also obtained for C3H mice (data not shown). Histogram height is displayed as Percentage 
of Maximum (% Max), meaning that peak heights within each graph are normalized to a percentage of the peak representing the highest event num-
ber on the X axis. The percent of Ly6G positive cells is shown above the peak response. At least 3 independent experiments, each containing 5 mice 
per group, are shown and isotype controls for all antibodies showed a staining pattern identical to the unstained controls (shaded histogram). B) In-
filtrating cells stained with other immune cell markers for α7WT and α7KO genotypes. C) Bone marrow granulocytes of α7WT and α7 KO mice double 
labeled for Ly6G and the more immature marker, Ly6C (granulocytes and neutrophils). Unlike infiltrating cells to the skin, these cells do not differ in 
resident bone marrow populations. D) Similar to Panel A, either α5KO mice or β4KO mice with corresponding WT controls were examined for Ly6G 
recruitment to the skin. The grey shaded histogram represents control unstained cells. E) Cells from ears of α7WT and α7KO mice were harvested 24 
hours post application of croton oil. Results reflect similar numbers of Ly6G positive cells at this later time.
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phocyte populations, Figure 2e) was observed between
the α7 WT and the α7KO mice. Thus, the absence of α7
appears to enhance the early response to an inflamma-
tory agent while not affecting neutrophil accumulation at
later times (24 hrs, discussed in the next section).
Chemokine expression differs in cells infiltrating the skin of 
α7KO mice
Cytokines and chemokines play a key role in normal cel-
lular trafficking and recruitment of cells to sites of
inflammation [11,19,20,26,27]. Both chemokine and
chemokine receptor expression is especially important to
rapid responses to assure cells are directed to the appro-
priate tissue sites. We determined the impact of α7 on
chemokine and chemokine receptor expression by the
infiltrating cell population. In the same experimental par-
adigm as above, infiltrating cells were harvested from ears
of α7WT or α7KO mice after exposure to croton oil for 6
hours. The RNA from these cells was analyzed using
commercially available microarray systems (SABiosys-
tems, see Methods) for cytokines, chemokines and
chemokine receptors. While the majority of the examined
signaling molecules did not vary between mice of differ-
ing genotypes (α7WT vs. α7KO), there were prominent
differences (Figure 3a). Among the most notable was the
expression of the chemokine receptor CCR10 where
expression was much greater in the α7KO infiltrating
cells. This result was verified using qPCR (Applied Bio-
sciences TaqMan primers) as shown in Figure 3b. CCR10
message was not detected in the skin of either the α7WT
or α7KO mouse (not shown).
Although signaling through the CCR10 chemokine
receptor is most often associated with lymphocytes
rather than neutrophils (discussed in next section), the
possibility that the expression of the ligand for this recep-
tor was also dysregulated was examined. This was done
independently of the arrays since the chemokine ligands
for CCR10, CCL27 and CCL28, were not included in the
arrays. Therefore, we measured CCL27 and CCL28 in
RNA from both infiltrating cells and resident skin of the
inflamed ear using TaqMan probes and qPCR. Neither
CCL27 nor CCL28 were detected in the RNA from infil-
trating cells of either the α7WT or α7KO mice (not
shown). This was not unexpected since the expression of
these ligands would be anticipated to be expressed by res-
ident cells at the site of the inflammatory stimulation in
order to recruit inflammatory cells. CCL27 in resident
cell RNA was detected and its expression was elevated in
the croton-oil exposed skin of the α7KO compared to the
α7WT mouse (Figure 3c).
Identity of CCR10 positive infiltrating cells
Because CCR10 expression is most often associated with
lymphocytes [28-30], the identity of CCR10 expressing
cells in the cellular infiltrates of croton oil treated mice
was examined. To determine if the infiltrating neutro-
phils described above were CCR10 positive, cells isolated
from animals (α7WT and α7KO) were co-labeled for
Ly6G and CCR10. As measured using flow cytometry,
Ly6G+ infiltrating cells were substantially increased in
α7KO mice (47% in the α7KO vs. 26% in α7WT, Figure
4a). Further, this difference was also reflected in the num-
ber of Ly6G+ cells expressing CCR10 (32% in α7KO vs.
18% in α7WT). However, the intensity of CCR10 staining
of these neutrophils is less than that observed for CCR10
positive cells of the bone marrow or spleen (Figure 4a).
We refer to the skin associated infiltrating neutrophils as
Ly6G+CCR10lo. Results in Figure 4a also show that the
majority of bone marrow cells that are Ly6G+ are not
CCR10 positive (but Ly6G+CCR10+ cells are definitely
present) and the majority of CCR10+ cells in the spleen
are not Ly6G+, but there is a large population of
Ly6GnegCCR10hicells. Differences in the number of
CCR10 positive cells between α7WT and α7KO in the
bone marrow or spleen were not observed. Therefore,
these results suggest a novel population of CCR10lo neu-
trophils that are recruited to the skin. The β4KO skin
infiltrate cells were also examined for the presence of
Ly6G+CCR10lo cells (Figure 4b). The results demonstrate
that Ly6G+CCR10lo cells constitute the majority of the
infiltrating population of cells but no difference between
the β4WT and β4KO in percentage of these cells is
observed. This result again points to the specificity of the
enhanced response in the α7KO mouse.
Finally, we tested whether other immune cells infiltrat-
ing the skin were CCR10 positive in the α7KO mouse. For
these measurements, cells (including T-cells, B-cells and
macrophages) collected from ears 6 hours post-inflam-
matory challenge were co-labeled with CCR10 and quan-
titated using flow cytometry analysis. As shown in Figure
4c, the difference between the α7KO and α7WT mice in
CCR10lo cells is present (as shown in Figure 4a) and these
CCR10lo staining cells are F480negB220negCD4negCD8neg.
Thus, croton oil challenge to the α7KO mouse results in a
greater number of Ly6G+CCR10lo, as compared to the
α7WT mouse, at the site of inflammation.
Other factors affecting cellular trafficking
Integrins and adhesion proteins also play a central role in
the proper trafficking and accumulation of cells at sites of
inflammation. The change in transcript expression of
some adhesion proteins including ICAM1, integrins α3
(Itga3) and β2 (Itgb2), and E-selectin were measured and
are shown in Figure 5. The results show that E-selection
(CD62E), which is normally present on endothelial cells,
is increased in the skin (resident cells) of the α7KO
mouse relative to the α7WT animal (Figure 5, bottom
panel) and is not detectable in the infiltrating cells (not
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vated in the α7KO mouse but not in the resident tissue of
α7KO mice where expression did not differ from the
α7WT. The β2 integrin expression did not differ between
α7WT and α7KO (not shown). ICAM-1 (CD54), which
can be expressed on a variety of cells including
hematopoietic cells and resident cells such as fibroblasts
and keratinocytes, is elevated in both the infiltrating cells
and the resident tissue of the α7KO mouse. Therefore,
selective differences in the expression of adhesion mole-
cules and chemokines are observed in the α7KO mouse
that could account for the increase in PMN recruitment
and accumulation to sites of inflammation.
Discussion
The skin is a site of frequent but localized pro-inflamma-
tory events. The rapid onset of local inflammatory pro-
cesses includes elevated cytokine and chemokine
production as well as cellular infiltration. Nicotinic ace-
tylcholine receptors (nAChR), while best characterized as
neurotransmitter receptors on neurons, also contribute
to host defenses in many tissues, including the skin,
Figure 3 Microarray analysis of infiltrating cells identifies the expression of the chemokine receptor CCR10 to be elevated in the α7KO. A) 
RNA collected from infiltrating cells from croton oil treated ears was analyzed using SABiosciences arrays. As indicated, the DeltaCt (cycle number to 
detect transcript after normalization to (β-actin and GAPDH) is inversely related to transcript number. The central line is the linear regression best fit 
(R2 = 0.95) and flanking dotted lines define the boundaries of statistical significance (p > 0.05). Individual error bars reflect ± the standard deviation. 
Transcripts that are different in expression between the α7WT and α7KO are boxed and their identity (CCR10, IL1f8 and CCl20) shown. Some additional 
transcripts that failed statistical significance are also identified. B) RT-PCR analysis (see Methods) of transcripts identified by microarray using Taqman 
gene expression. There is a good qualitative match with the microarray data. C) A similar analysis of the total ear skin depleted of infiltrating cells re-
vealed no detectable changes in transcript expression that were confirmed by RT-PCR. Analyses for transcripts not on the array such as CCL27 and 
CCL28 (the ligands for CCR10) present in resident cells of the ear skin were included (* p < 0.01). Neither CCL27 nor CCL28 were detectable in infiltrat-
ing cells (not shown).
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more recognized role in modulating neurotransmission
[1-3,6,31]. A prominent nAChR composed of the α7 sub-
unit, as well as its endogenous agonists acetylcholine and
choline, are expressed by keratinocytes [6,32,33]. The sta-
tus of acetylcholine production by cells in the skin, other
than keratinocytes and especially in the context of the
inflammatory response, remains to be fully explored. The
nAChRs are also responsive to the exogenous agonist,
nicotine. Much of what we know about the role of this
receptor in inflammation has been found through exam-
ining cultured cell systems or the mouse model (espe-
cially mice lacking α7 expression, α7KO). Many studies
have demonstrated that in the absence of α7, the response
to inflammatory stimuli is elevated. This includes the
influence of α7 on inflammatory pro-inflammatory
cytokine signaling (e.g., TNFα [7]), damped inflamma-
tory cytokine expression by macrophages (see [34] but
also see [35]), altered subsequent adaptive immune
responses including antibody production [36], and shifts
in inflammatory responses in tissues receiving vagal
nerve innervation [34,37]. In the lung, an influence by α7
Figure 4 Ly6G+ infiltrating cells co-express CCR10. A) Ly6G+/CCR10+ infiltrating cells 6 hours after croton oil. Ly6G cells from the skin express low 
levels of CCR10 (CCR10lo). There are more Ly6G+CCR10lo cells present in the α7KO (32%) versus the WT (18%). The numbers reflect percentage of cells 
rounded to the whole number. Analysis of bone marrow or spleen reveal no difference in neutrophil numbers relative to genotype as reported [28,30]. 
Isotype controls were identical to unstained controls (not shown). B) The percentage of Ly6G+CCR10lo cells elicited by croton oil application to the 
β4WT or β4KO mice was equivalent. C) Croton oil induced infiltrating cells were also examined for co-expression of CCR10 with other immune cell 
markers including macrophages (F4/80), B-cells (B220) and T-cells (CD4 or CD8).
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Page 10 of 13on acid-induced acute lung injury in the mouse model is
observed and includes elicitation of more inflammatory
cytokines in the α7KO over the α7WT animals [38]. This
increase in lung inflammatory cytokines in the α7KO
mice is associated with more severe lung injury than the
WT mice suggesting that this receptor plays a regulatory
role in balancing the inflammatory processes in the lung.
In a previous report [8] we demonstrated that α7KO mice
elicit a greater response to a common environmental
inflammatory agent, ultraviolet radiation (UVR). The
skin does not receive significant parasympathetic or any
vagal innervation indicating that these neuronal systems
are not directly required for α7 to impact on these pro-
cesses. A more local control of signaling is also supported
by studies examining keratinocytes cultured in vitro
which express nAChRs, including α7, and these impact
upon multiple cellular processes including cell migration
and the expression of various chemokines and adhesion
molecules [39-43]. Thus, it can be hypothesized that the
role of α7 in normal inflammatory responses in the skin
are likely responsive to acetylcholine or choline and sug-
gest that the normal physiologic function of this nAChR
in regulating inflammation is customized according to
tissue, cell type and neuronal complexity.
In this report the lack of α7 was found to modifying cel-
lular infiltration to a local inflammatory stimulus of the
skin. As reported previously, the lack of α7 expression
(α7KO mice) corresponds with modulation of pro-
inflammatory molecules such as IL-1β and IL-6 [7,8,44].
We now find this includes an early enhancement of neu-
trophil infiltration to an inflamed area of the skin that is
not due to increased numbers of available neutrophils in
the bone marrow or spleen of the α7KO mouse. Consis-
tent with altered recruitment of neutrophils is a coinci-
dent increase in expression by the α7KO mouse of the
skin-associated signaling chemokine, CCL27, and its
receptor (CCR10) that is expressed by responding infil-
trating cells. This is significant in terms of identifying
potential specific contributors in these interactions. The
chemokine system, consisting of four gene families dis-
tinguished by the position of their cysteine residues
[19,20], is complicated by the considerable promiscuity in
ligand-receptor interactions and tissue diversity in
expression (for detailed review see [19]). In general, lym-
phocytes are reported to express predominantly CCR
receptors that interact with CC chemokines. In contrast,
neutrophils express predominantly CXCR receptors that
interact with the CXC chemokines. Recruitment of cells
to the skin through elicitation by CCL27 is not unex-
pected since this chemokine is known to be induced by
specific skin-inflammatory cell interactions [28-30].
However, CCR10 expression by neutrophils has to our
knowledge not been reported. Our results find that the
neutrophils, as defined by Ly6G (and co-expression of
Ly6C) expression, are recruited in both the α7WT and
the α7KO mouse and these cells also exhibit CCR10
expression. The skin infiltrating cells from the α7KO
mice also express elevated RNA transcripts for this
chemokine receptor. Notably, the majority of the infiltrat-
ing Ly6G+ neutrophils were CCR10 positive but stained
less intensely for this marker than neutrophils in the bone
marrow or spleen. Further, in the bone marrow and
spleen the majority of CCR10 positive cells are not
Ly6G+. The significance of this population of neutrophils
in the skin and their characterization as Ly6G+CCR10lo
remains to be investigated further. A recent report [45]
showing that α7KO mice elicit an accelerated clearance of
E. coli injected into the peritoneum of mice through a
more rapid recruitment of neutrophils to the site of infec-
Figure 5 The expression of adhesion molecule transcripts is al-
tered by α7 expression. Examination of infiltrating cells and resident 
cells after croton oil treatment for 6 hours reveals that certain mole-
cules important to cell recruitment and localization to inflamed tissue 
are expressed. As shown using qPCR, in α7KO mice transcripts for 
ICAM1 are enhanced considerably in infiltrating cells and to a lesser ex-
tent in resident cells relative to controls (WT mice values normalized to 
1 were used to determine fold increase observed in the KO). Itga3 tran-
scripts are increased in α7KO infiltrating cells. In contrast, E-selectin 
transcripts are elevated in resident cells (ear skin depleted of infiltrating 
cells) and especially in the α7KO, but these transcripts were not detect-
ed in infiltrating cells. Error bars represent standard error of the mean; 
* p < 0.05; ** p < 0.01.
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ized to include sites other than the skin. However, it is
noteworthy that the impact by α7KO on bacterial clear-
ance was transient during the early phase of bacterial
infection [45]. Our results are consistent with the role of
α7 being most important early in an inflammatory
response where it appears to limit (or in the case of the
α7KO enhance) the magnitude of initiating events. This
in turn would correspond with control of greater tissue
damage as has been suggested from studies of lung
responses in α7KO mice [38] and our report that the skin
of the α7KO mouse demonstrates greater edema and
thickness following ultraviolet radiation of back skin [8].
Another alteration in α7KO mice is a change in the
expression of adhesion molecules in both the target tissue
and the trafficking cells. The specificity of the expression
of adhesion molecules by either infiltrating cells (e.g.,
Itga3 in Figure 5) or resident cells (e.g., E-selectin Figure
5) is also notable. This suggests that α7 expression in the
skin influences multiple mechanisms downstream of
receptor activation including shifts in cytokines and
chemokines that will subsequently have a broad effect on
many cells in the environment regardless of their α7
expression status.
The presence of sustained nicotine exposure, which
impacts all nAChRs, would likely introduce an imbalance
to cellular pathways, of which α7 is a modulatory compo-
nent. Similar to neurological systems where imbalance in
nAChR expression leads to phenotypes of addiction [1],
the interaction between nAChRs and pro-inflammatory
systems is also finely balanced. For example, it has been
reported that acne and eczema are more common in non-
smokers suggesting that nicotine may actually dampen
specific inflammatory responses in the skin leading to
these diseases [46,47]; Or, such responses may reflect an
altered 'tone', perhaps demonstrated by elevated baseline
levels of inflammatory cytokines. This is not inconsistent
with the calming effects of nicotine on the inflammatory
bowel disease ulcerative colitis (UC) and where cessation
of smoking correlates with an induced flare in this disease
(see [3]). However, nicotine exacerbates Crohns disease
[48-52], a related inflammatory bowel disease of different
pathology. That the active compound is nicotine has been
demonstrated many times with delivery of this com-
pound through patches placed on rats, mice and in some
cases humans and appears to reverse some inflammatory
symptoms while exacerbating others [53,54]. These inter-
esting associations again point to the fact that we have
much to learn about nAChR regulation of inflammation
in different tissues whose mechanism(s) reflect a summa-
tion of the impact by multiple nAChRs and intracellular
signaling systems. Further, smoking is associated with
premature aging of skin which may be a result of nicotine
effects on the normal responses of the nicotinic receptors
in this tissue.
Conclusion
This study finds that mice lacking nAChRα7 have ele-
vated levels of neutrophils in the skin following topical
application of a skin irritant. The α7KO mice, indepen-
dent of the mouse strain backgrounds tested, have ele-
vated inflammatory cytokines (IL-1β and IL-6, but not
necessarily TNFα) and increased expression of adhesion
molecules and chemokines that are important to recruit-
ment of the pro-inflammatory cells to the skin. One chal-
lenge remaining will be to determine if such regulatory
interactions among nAChR and inflammatory systems
are equally customized to the microenvironment of other
organs such as gut, secondary lymphoid organs, as well as
the brain.
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